Drug Delivery to the Lungs 28
from November 13–17, 2016
MEGGLE Business Group
BG Excipients & Technology
MEGGLE USA expands direct sales & marketing in the US & Puerto Rico
MEGGLE USA Inc. (USA), a subsidiary of MEGGLE AG (Germany), announces the expansion of its sales and marketing capabilities in North America. MEGGLE has historically used a distribution sales model, but will now support its customer base in the US and Puerto Rico through direct sales and warehousing.
After having established offices and manufacturing capacity in North America, MEGGLE will now focus on improved access, services and capabilities in North America. Beginning October 1st, 2016, MEGGLE USA will move to a direct sales model and change from the historical distribution channel.
“We are very pleased to announce this expansion. Moving from distribution to a direct sales and warehousing model will allow us to better serve the needs of our pharmaceutical customers. With our growing presence as a leading excipient supplier in the North America market, the move to a direct sales model will improve our ability to service and support our customers’ needs,” said Ken Seufert, Managing Director for MEGGLE USA, Inc. “This will allow for more flexibility, faster reaction time and improved technical support to our existing customers, as well as pave the way for future growth.”
MEGGLE USA, Inc.
Rishi Pimentel, +1 844 4MEGGLE (+1 844 463 4453)
13. - 15. September 2017